Day 2 - Morning

Group 4A: Metastatic Breast Cancer; ER+; Novel Drugs Sold Out

Group 4B: Metastatic Breast Cancer; Cancer Genomics; Clinical Outcomes

Group 4C: Early-Stage Breast Cancer; ER+; Risk of Recurrence; Survival Outcomes Sold Out

Group 4D: Breast Cancer; Microbiome; Immunotherapy Sold Out

Group 4F: Metastatic Breast Cancer; Immunotherapy; Vaccines; Tumor Microenvironment Last Few Tickets

Group 4G: Metastatic Breast Cancer; ER+; Treatment Resistance; Basic Science; Tumor Microenvironment Last Few Tickets

Group 4H: Breast Cancer; Microbiome; Immunotherapy